FIELD: medicine.
SUBSTANCE: present invention relates to new compounds selected from the following group of compounds: (1R,2R,4S)-rel-N-(3-(pentafluorosulfanyl)benzyl)bicyclo[2.2.1]heptane-2-carboxamide; (1S,2S,4R)-N-(3-(pentafluorosulfanyl)benzyl)bicyclo[2.2.1]heptane-2-carboxamide; 5-chloro-N-(4-(pentafluorosulfanyl)benzyl)thiophene-2-carboxamide, and a pharmaceutical composition for the prevention or treatment of a disorder related to aberrant activity of potassium channels.
EFFECT: compounds can be used as a drug for the prevention or treatment of hearing loss of the inner ear after damage or loss of sensory hair cells in the cortical organ.
6 cl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NEW COMPOUNDS USED AS POTASSIUM CHANNEL OPENERS | 2018 |
|
RU2779111C2 |
| NON-AQUEOUS GEL COMPOSITION | 2021 |
|
RU2822601C1 |
| 2-OXA-5-AZABICYCLO[2.2.1]HEPTANE-3-YL DERIVATIVES | 2015 |
|
RU2697651C2 |
| APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
| CATHEPSIN CYSTEINE PROTEASE INHIBITORS | 2014 |
|
RU2692799C2 |
| SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE DERIVATIVES OF PYRIMIDINES, COMPOSITIONS THEREOF AND METHODS OF TREATING USE THEREOF | 2012 |
|
RU2697712C2 |
| DERIVANTS OF BICYCLO[2, 2, 1] HEPT-7-YLAMINE AND THEIR APPLICATIONS | 2006 |
|
RU2442771C2 |
| DERIVATIVES OF PYRAZOLE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND INTERMEDIATE COMPOUNDS OF SYNTHESIS | 1993 |
|
RU2119917C1 |
| SUBSTITUTED DIAMINO-CARBOXAMIDE AND DIAMINO-CARBONITRILE PYRIMIDINE DERIVATIVES, THEIR COMPOSITIONS AND METHODS OF TREATMENT USING THEM | 2012 |
|
RU2625309C2 |
| BORONIC ACID DERIVATIVES | 2018 |
|
RU2793315C2 |
